Friday, 7th of December 2018 |
Four items on microneedle patches for vaccine administration
Rouphael NG, Paine M, Mosley R, Henry S, McAllister DV, Kalluri H, Pewin W, Frew PM, Yu T, Thornburg NJ, Kabbani S, Lai L, Vassilieva EV, Skountzou I, Compans RW, Mulligan MJ, Prausnitz MR; TIV-MNP 2015 Study Group.
Lancet. 2017 Aug 12;390(10095):649-658.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)30575-5/fulltext
Long-term stability of influenza vaccine in a dissolving microneedle patch.
Mistilis MJ, Joyce JC, Esser ES, Skountzou I, Compans RW, Bommarius AS, Prausnitz MR.
Drug Deliv Transl Res. 2017 Apr;7(2):195-205.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003766/
.
Microneedle patches for vaccination in developing countries.
Arya J, Prausnitz MR.
J Control Release. 2016 Oct 28;240:135-141.
https://www.ncbi.nlm.nih.gov/pubmed/26603347
A microneedle patch containing measles vaccine is immunogenic in non-human primates.
Edens C, Collins ML, Goodson JL, Rota PA, Prausnitz MR.
Vaccine. 2015 Sep 8;33(37):4712-8.
https://www.ncbi.nlm.nih.gov/pubmed/25770786
.Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
40756971 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |